AMBIENTUM BIOETHICA BIOLOGIA CHEMIA DIGITALIA DRAMATICA EDUCATIO ARTIS GYMNAST. ENGINEERING EPHEMERIDES EUROPAEA GEOGRAPHIA GEOLOGIA HISTORIA HISTORIA ARTIUM INFORMATICA IURISPRUDENTIA MATHEMATICA MUSICA NEGOTIA OECONOMICA PHILOLOGIA PHILOSOPHIA PHYSICA POLITICA PSYCHOLOGIA-PAEDAGOGIA SOCIOLOGIA THEOLOGIA CATHOLICA THEOLOGIA CATHOLICA LATIN THEOLOGIA GR.-CATH. VARAD THEOLOGIA ORTHODOXA THEOLOGIA REF. TRANSYLVAN
The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary
The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.
Authors: ALI NADERI, AKIN AKINCIOĞLU, AHMET ÇAĞAN, SÜLEYMAN GÖKSU, PARHAM TASLIMI, İLHAMI GÜLÇIN.
DOI: 10.24193/subbchem.2023.2.10
Published Online: 2023-06-30
Published Print: 2023-07-30
pp. 145-168
VIEW PDF
FULL PDF
Starting from commercially available 4-phenylbutanoic acids, a series of novel sulfamides were synthesized and investigated for their inhibition properties on the human carbonic anhydrase I and II (hCA I and II), acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes. SAR was also evaluated with molecular docking study. These new compounds were tested against hCA I and hCA II, BChE, and AChE. The majority of the synthetic compounds were more effective against AChE than tacrine, a common inhibitor. Additionally, tacrine was not the only synthetic substance that was more effective against BChE. The obtained results revealed that N,N-dimethyl-[3-(2,4-dimethoxyphenyl)propyl]sulfamide 25, with Ki of 94.22±42.37 nM against AChE and Ki of 230.91±46.22 nM against BChE, was the most potent compound against cholinesterase enzymes. These recently created substances were tested for their ability to inhibit hCA I and II isoforms. In comparison to the conventional inhibitor acetazolamide, the majority of produced sulfamide derivatives 25–29 also inhibited these investigated isoforms. In particular, sulfamide derivatives 25-29 with substituents N,N-dimethyl-[3-(3,5-dimethoxyphenyl)propyl]sulfamide 26 and N,N-dimethyl-[3-(3,4-dimethoxyphenyl)propyl]sulfamide 27 emerged as the most potent hCA inhibitors.
Keywords: Synthesis; 3-phenylbutylamine; sulfamide; biological effects; molecular docking
